Cargando…

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma

Corticotropin releasing hormone binding protein (CRHBP) mediates the reaction between corticotropin releasing hormone (CRH) and corticotropin releasing hormone receptors (CRHRs). It is expressed in a number of organs, and the expression of CRHBP is associated with tumorigenesis and cancer progressio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xia, Hai-Bing, Wang, Hui-Ju, Fu, Luo-Qin, Wang, Shi-Bing, Li, Li, Ru, Guo-Qing, He, Xiang-Lei, Tong, Xiang-Min, Mou, Xiao-Zhou, Huang, Dong-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096283/ https://www.ncbi.nlm.nih.gov/pubmed/30127978 http://dx.doi.org/10.3892/ol.2018.9073

Ejemplares similares

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis
por: Yang, Kang, et al.
Publicado: (2019)

High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma
por: Song, Shu-Shu, et al.
Publicado: (2020)

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
por: Huang, Yan, et al.
Publicado: (2012)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

Claudin‐1 correlates with poor prognosis in lung adenocarcinoma
por: Sun, Bing‐sheng, et al.
Publicado: (2016)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Bu, Yang, et al.
Publicado: (2016)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
por: He, Fei, et al.
Publicado: (2015)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

Low expression of citron kinase is associated with poor patient outcomes in hepatocellular carcinoma
por: Zhang, Huan-Qing, et al.
Publicado: (2020)

Characterization of CRH-Binding Protein (CRHBP) in Chickens: Molecular Cloning, Tissue Distribution and Investigation of Its Role as a Negative Feedback Regulator within the Hypothalamus–Pituitary–Adrenal Axis
por: Wan, Yiping, et al.
Publicado: (2022)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

Decreased let-7b is associated with poor prognosis in glioma
por: Zhang, Wanzeng, et al.
Publicado: (2019)

Decreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC
por: Xiang, Yinzhou, et al.
Publicado: (2017)

Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Wang, Dan-dan, et al.
Publicado: (2012)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Chen, Jian-yao, et al.
Publicado: (2017)

Overexpression of ST3Gal-I promotes migration and invasion of HCCLM3 in vitro and poor prognosis in human hepatocellular carcinoma
por: Wu, Han, et al.
Publicado: (2016)

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Huang, Chun-yu, et al.
Publicado: (2013)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer
por: Sun, Ming, et al.
Publicado: (2014)

Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma
por: Li, Guang-Zhen, et al.
Publicado: (2021)

Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
por: Li, Aimin, et al.
Publicado: (2015)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Jing, Ji-sheng, et al.
Publicado: (2018)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma
por: He, Hai-Xia, et al.
Publicado: (2021)

Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome
por: Zhao, Zhen-guo, et al.
Publicado: (2016)

Increased expression of urotensin II is associated with poor prognosis in hepatocellular carcinoma
por: Liu, Dian-Gang, et al.
Publicado: (2016)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Decreased Expression of the GATA3 Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma
por: Keshari, Rajiv Prasad, et al.
Publicado: (2014)

Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression
por: Liao, Wen-Ting, et al.
Publicado: (2009)

Decreased E2F2 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Colorectal Cancer
por: Shang, Yuanyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9fpupa5lduag7gccb3pnstcbc0